HLA

Journal Title

HLA

HLA

ISSN / eISSN

2059-2302 / 2059-2310

Aims and Scope

HLA publishes full-length original articles, brief communications, commentaries and reviews covering all aspects of genetic control of immunity. The scope includes functional, biochemical, and genetic studies on molecules of the immune system, including cell surface receptors and their ligands, and encompassing cytokines, and chemokines, adhesion and co-stimulating molecules, antigen receptors such as TcR, NKR, CD1, PAMPs, Igs, KIR, and genes and products of the major histocompatibility complex including classical and non-classical HLA molecules. Papers should describe original research in vitro, or in animal models, or be clinical studies reflecting genetics of immunity in solid organ or haematopoietic stem cell transplantation, autoimmunity, infectious immunity, allergy, tumour immunity, vaccine science, pregnancy and disease susceptibility.

Subject Area

CELL BIOLOGY

IMMUNOLOGY

PATHOLOGY

CiteScore

3.00 View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Immunology and Allergy	Q3	#160/233
Medicine - Genetics	Q3	#258/347
Medicine - Immunology	Q4	#179/236

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2024)	Quartile
CELL BIOLOGY	Q2
IMMUNOLOGY	Q1
PATHOLOGY	Q1

H-index

93

Country/Area of Publication

UNITED STATES

Publisher

Wiley-Blackwell Publishing Ltd

Annual Article Volume

94

Open Access

NO

Contact

111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774